These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 37000351)

  • 1. Minnelide Markedly Reduces Proteinuria in Mice with Adriamycin Nephropathy by Protecting Against Podocyte Injury.
    Ji B; Liu J; Ma Y; Yin Y; Xu H; Shen Q; Yu J
    Appl Biochem Biotechnol; 2023 Dec; 195(12):7379-7396. PubMed ID: 37000351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minnelide combined with anti-ANGPTL3-FLD monoclonal antibody completely protects mice with adriamycin nephropathy by promoting autophagy and inhibiting apoptosis.
    Ji B; Liu J; Yin Y; Xu H; Shen Q; Yu J
    Cell Death Dis; 2023 Sep; 14(9):601. PubMed ID: 37689694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minnelide combined with Angptl3 knockout completely protects mice with adriamycin nephropathy via suppression of TGF-β1-Smad2 and p53 pathways.
    Ji B; Liu J; Ma Y; Yin Y; Xu H; Shen Q; Yu J
    Int Immunopharmacol; 2023 Feb; 115():109656. PubMed ID: 36608441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IP
    Xu H; Guan N; Ren YL; Wei QJ; Tao YH; Yang GS; Liu XY; Bu DF; Zhang Y; Zhu SN
    BMC Nephrol; 2018 Jun; 19(1):140. PubMed ID: 29907098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective role of cyclosporine A and minocycline on mitochondrial disequilibrium-related podocyte injury and proteinuria occurrence induced by adriamycin.
    Guan N; Ren YL; Liu XY; Zhang Y; Pei P; Zhu SN; Fan Q
    Nephrol Dial Transplant; 2015 Jun; 30(6):957-69. PubMed ID: 25646018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcineurin inhibitors ameliorate PAN-induced podocyte injury through the NFAT-Angptl4 pathway.
    Shen X; Zhang Y; Lin C; Weng C; Wang Y; Feng S; Wang C; Shao X; Lin W; Li B; Wang H; Chen J; Jiang H
    J Pathol; 2020 Nov; 252(3):227-238. PubMed ID: 32686149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-ANGPTL3-FLD monoclonal antibody treatment ameliorates podocyte lesions through attenuating mitochondrial damage.
    Lv Q; Han X; Ni J; Ma Q; Dai R; Liu J; Liu J; Zhai Y; Shen Q; Sun L; Liu H; Rao J; Xu H
    Cell Death Dis; 2022 Oct; 13(10):867. PubMed ID: 36229446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of rituximab on puromycin-induced apoptosis, loss of adhesion and cytoskeletal alterations in human podocytes.
    Jeruschke S; Alex D; Hoyer PF; Weber S
    Sci Rep; 2022 Jul; 12(1):12297. PubMed ID: 35853959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome.
    Koshikawa M; Mukoyama M; Mori K; Suganami T; Sawai K; Yoshioka T; Nagae T; Yokoi H; Kawachi H; Shimizu F; Sugawara A; Nakao K
    J Am Soc Nephrol; 2005 Sep; 16(9):2690-701. PubMed ID: 15987752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Administration of pigment epithelium-derived factor (PEDF) reduces proteinuria by suppressing decreased nephrin and increased VEGF expression in the glomeruli of adriamycin-injected rats.
    Fujimura T; Yamagishi S; Ueda S; Fukami K; Shibata R; Matsumoto Y; Kaida Y; Hayashida A; Koike K; Matsui T; Nakamura K; Okuda S
    Nephrol Dial Transplant; 2009 May; 24(5):1397-406. PubMed ID: 19042927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Qi-Dan Fang ameliorates adriamycin-induced nephrotic syndrome rat model by enhancing renal function and inhibiting podocyte injury.
    Wu JB; Ye SF; Liang CL; Li YC; Yu YJ; Lai JM; Lin H; Zheng J; Zhou JY
    J Ethnopharmacol; 2014 Feb; 151(3):1124-1132. PubMed ID: 24389029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiopoietin-like-3 knockout protects against glomerulosclerosis in murine adriamycin-induced nephropathy by attenuating podocyte loss.
    Dai R; Liu H; Han X; Liu J; Zhai Y; Rao J; Shen Q; Xu H
    BMC Nephrol; 2019 May; 20(1):185. PubMed ID: 31126248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab protects podocytes and exerts anti-proteinuric effects in rat adriamycin-induced nephropathy independent of B-lymphocytes.
    Takahashi Y; Ikezumi Y; Saitoh A
    Nephrology (Carlton); 2017 Jan; 22(1):49-57. PubMed ID: 26833819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hsp90 inhibition aggravates adriamycin-induced podocyte injury through intrinsic apoptosis pathway.
    Dong J; Jiang Z; Ma G
    Exp Cell Res; 2020 May; 390(2):111928. PubMed ID: 32156599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineering antioxidant ceria-zirconia nanomedicines for alleviating podocyte injury in rats with adriamycin-induced nephrotic syndrome.
    Liu L; Chang M; Yang R; Ding L; Chen Y; Kang Y
    J Nanobiotechnology; 2023 Oct; 21(1):384. PubMed ID: 37858242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leonurine ameliorates adriamycin-induced podocyte injury via suppression of oxidative stress.
    Liu X; Cao W; Qi J; Li Q; Zhao M; Chen Z; Zhu J; Huang Z; Wu L; Zhang B; Yuan Y; Xing C
    Free Radic Res; 2018 Sep; 52(9):952-960. PubMed ID: 30334481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Podocyte protection by darbepoetin: preservation of the cytoskeleton and nephrin expression.
    Eto N; Wada T; Inagi R; Takano H; Shimizu A; Kato H; Kurihara H; Kawachi H; Shankland SJ; Fujita T; Nangaku M
    Kidney Int; 2007 Aug; 72(4):455-63. PubMed ID: 17457371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autophagy is activated to protect against podocyte injury in adriamycin-induced nephropathy.
    Yi M; Zhang L; Liu Y; Livingston MJ; Chen JK; Nahman NS; Liu F; Dong Z
    Am J Physiol Renal Physiol; 2017 Jul; 313(1):F74-F84. PubMed ID: 28404589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of tadalafil on damaged podocytes in an adriamycin-induced nephrotic syndrome model.
    Tomita N; Hotta Y; Naiki-Ito A; Sanagawa A; Kataoka T; Furukawa-Hibi Y; Takahashi S; Kimura K
    J Pharmacol Sci; 2022 Jun; 149(2):53-59. PubMed ID: 35512855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tripterygium glycoside fraction n2 ameliorates adriamycin-induced nephrotic syndrome in rats by suppressing apoptosis.
    Wang XW; Tian RM; Yang YQ; Wang K; Li EN; Han XD; Bao K; Mao W; Xu HT; Liu B; Xu P
    J Ethnopharmacol; 2020 Jul; 257():112789. PubMed ID: 32234597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.